Assistant Professor of Medicine at Stanford University

Joined December 2014
1 Photos and videos
Grateful to the Stanford Center for Digital Health for supporting our work with @jure on prototyping AI models and agents for T cell therapy design.
We're excited to introduce the 2026 Stanford Center for Digital Health Grant Awardees, a cohort of scientists working on projects that can transform health. Please join us in celebrating this exceptional group of researchers from across @stanford. cdh.stanford.edu/research-po…
1
8
407
Zinaida Good retweeted
We asked the best AI researchers in the world one question: if you had the resources, how would you use AI to solve humanity's hardest problems? Today we're sharing what came back. Moonshots // ONE is live. 🧵 laude.org/moonshots
3
16
81
64,803
Zinaida Good retweeted
21 Nov 2025
Excited to present the first major work after starting our lab at Stanford and the Arc this year: CRISPR-All, a unified genetic perturbation language for programming any major type of genetic perturbation simultaneously, in any combination, at genome scale, in human cells.
9
102
402
154,483
We're excited to release tcellMIL, an attention-based multiple instance learning model for predicting patient outcomes after CAR T cell therapy for lymphoma and nominating cell design strategies in #neurips2025 AI4D3! ai4d3.github.io/2025/papers/…

2
6
38
3,387
It's exciting to share our mini-review on #Treg cell therapies out today in Frontiers in Immunology! Earning a #NobelPrize this year, Tregs have been tested in >69 clinical trials and are moving towards initial approvals. frontiersin.org/journals/imm…
9
398
Today is my first day as an Assistant Professor of Medicine at Stanford University! My research program is focused on understanding and enhancing engineered T cell immunotherapies for cancer and immune-mediated diseases. If interested in joining please reach out!
83
171
1,616
112,095
This would not be possible without my mentors, especially Crystal Mackall, @sylviaplevritis, @GarryPNolan, Sean Bendall, David Miklos, and Michael Gold - THANK YOU!
1
27
6,405
Very proud of Anne Marijn Kramer to present 2 orals and a poster at #ASH2024, especially our work on CD22-CAR! Session 702 Dec 9 at 2:45 PM San Diego Convention Center, Room 6CF Title: CD22-Directed CAR T Cell Single Cell Multiomic Features Associated with IEC-HS
1
10
3,348
So proud of Kelvin Mo to give his first talk at #ASH2024! Session 702 Dec 7 at 4:00 PM Manchester Grand Hyatt San Diego, Grand Hall C Title: CCL8/CCL13-Producing Tumor-Associated Macrophages Linked to Poor Outcomes after CAR T Cell Therapy for LBCL
4
2,090
What an honor to give my first invited talk at #ASH2024. I am so grateful to my mentors Crystal Mackall, Sylvia Plevritis, and David Miklos for enabling me to get here! Dec 8 at 4:30 PM, San Diego Conv. Center, Room 33 Cellular Heterogeneity and Relationship to Clinical Outcomes
12
1,408
Our Stanford Center for Cancer Cell Therapy is excited to offer a Postdoctoral Fellow position at the interface between machine learning and T cell therapies: postdocs.stanford.edu/prospe…

1
6
21
3,700
Zinaida Good retweeted
Boom Capital is hiring a Chief of Staff. 🚀 This is one of our most important hires. You'll liaise with our in-house scientific society and impact every aspect of a VC firm, serving unprecedented ideas, scientists and engineers. Join boomcap.co and apply here: tinyurl.com/2xm65tja
7
27
79
40,865
Grateful to give an invited talk at the 6th Annual #Treg-Directed Therapies Summit! Please join us in Boston this May 21-23. treg-directed-therapies.com/
2
17
1,400
Honored to be interviewed by @10xGenomics to discuss our work with @SRamakrishna_MD , @MackallLab, and @michelle_monje on GD2-CAR T cell therapy for pediatric brain cancer.
#CART therapy is a good treatment for blood cancers, and @SRamakrishna_MD and @GoodZinaida think it has potential for kids with fatal brain cancer, too. Hear more about their #singlecell study, in collaboration with @parkerici, in our latest blog post ⬇️ 10xgen.com/3ZMqWoF
17
2,455
Thanks @TeikoBio for highlighting our work with @jayspiegel25, @BitaSahaf, @MackallLab, David Miklos, and team on defining the role of CAR Treg cells in progression following #CART therapy for lymphoma.
14 Feb 2023
Axi-cel is effective in only 40% of large B cell lymphoma (LBCL) patients and 69% experience neurotoxicity. Using mass cytometry, @GoodZinaida et al profiled post-infusion CAR T cells in LBCL patients to identify markers of response and neurotoxicity. teiko.bio/good-2022
7
1,378
Thanks to @statnews for covering our work identifying CAR Treg cells as limiting efficacy, toxicity, and expansion of CD19-CAR in lymphoma. Full article in @NatureMedicine here: rdcu.be/cVqVr. statnews.com/2022/10/04/why-…

1
3
16
Zinaida Good retweeted
To accelerate development of effective T cell therapies for cancer, there's an urgent need to decipher the attributes of the ideal therapeutic T cell Read the Meeting Report from the Parker Institute & 10x Genomics @SamanthaBucktr1 @parkerici @10xGenomics nature.com/articles/s41591-0…
10
41
In collaboration with @parkerici scientists and @10xGenomics, we wrote a commentary on "Advancing T cell–based cancer therapy with single-cell technologies" just out in @NatureMedicine: rdcu.be/cVXK8

6
21